ValiRx plc (LON:VAL – Get Free Report)’s share price dropped 12.8% during mid-day trading on Monday . The stock traded as low as GBX 0.53 ($0.01) and last traded at GBX 0.57 ($0.01). Approximately 9,117,890 shares were traded during trading, a decline of 22% from the average daily volume of 11,719,508 shares. The stock had previously closed at GBX 0.65 ($0.01).
ValiRx Price Performance
The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65. The business’s fifty day simple moving average is GBX 0.72 and its 200 day simple moving average is GBX 1.36. The stock has a market cap of £2.45 million, a price-to-earnings ratio of -0.43 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Best Aerospace Stocks Investing
- 3 Industry Leading Stocks Just Raised Dividends by 10% or More
- Best Stocks Under $10.00
- Twilio, Braze: The Top 2 CEP Platforms to Own in 2025
- What is diluted earnings per share (Diluted EPS)?
- Tempus AI Is a Buy, If You Can Handle the Volatility
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
